Net profit of Procter & Gamble Health declined 21.34% to Rs 46.56 crore in the quarter ended March 2024 as against Rs 59.19 crore during the previous quarter ended March 2023. Sales declined 21.33% to Rs 252.48 crore in the quarter ended March 2024 as against Rs 320.92 crore during the previous quarter ended March 2023.
| Particulars | Quarter Ended |
| | Mar. 2024 | Mar. 2023 | % Var. |
| Sales | 252.48 | 320.92 | -21 |
| OPM % | 26.71 | 24.82 | - |
| PBDT | 69.56 | 84.42 | -18 |
| PBT | 62.72 | 78.53 | -20 |
| NP | 46.56 | 59.19 | -21 |